Literature DB >> 9621984

Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.

M de Martino1, M E Rossi, C Azzari, M G Gelli, L Galli, A Vierucci.   

Abstract

We investigated the relationship between CD4+CD38+, CD4+HLA-DR+, CD8+CD38+, and CD8+HLA-DR+ cell proportions (HLA-DR = major histocompatibility complex class II) (determined by two-color immunofluorescence) and the clinical condition, IL-2 and IL-6 production, viral RNA copy numbers, and the eventual immunologic-virologic course in 25 children perinatally infected with HIV-1 surviving longer than 5 y [median age, 92 (range, 63-136) mo]. Twelve healthy age-matched children were studied as control subjects. HIV-1+ children had lower percentages and absolute numbers of CD4+CD38+, whereas the percentages of CD4+HLA-DR+ and the percentages and absolute numbers of CD8+CD38+ and CD8+HLA-DR+ cells were higher than that of control subjects. The absolute numbers of CD4+ and the percentages of CD4+CD38+, CD8+CD38+, and CD8+HLA-DR+ cells directly correlated, whereas the percentages of CD4+CD38+ and CD4+HLA-DR+ cells, the percentages of CD4+CD38+ and CD8+CD38+ cells, the CD8+ cell absolute numbers, and the percentages of CD8+CD38+ cells did not. Severe manifestations and immunologic deterioration occurred in children with low CD4+CD38+ cell percentages, whereas virologic worsening was associated with low CD8+CD38+ and CD8+HLA-DR+ cell percentages. IL-2 production directly correlated with percentages and absolute numbers of CD4+CD38+ and CD8+CD38+ cells. RNA copy numbers inversely correlated with CD4+CD38+, CD4+HLA-DR+, CD8+CD38+, and CD8+HLA-DR+ cell percentages. This suggests that CD38 molecule expression on both CD4+ and CD8+ cell subsets is a favorable marker in HIV-1+ children. Perhaps CD8+CD38+ subsets are activated cells, whereas CD4+CD38+ subsets are immature cells, possibly the host's attempt at CD4+ cell renewal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621984     DOI: 10.1203/00006450-199806000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children.

Authors:  Suad Kapetanovic; Lisa Aaron; Grace Montepiedra; Sandra K Burchett; Andrea Kovacs
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

2.  Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.

Authors:  S Resino; J Navarro; J M Bellón; D Gurbindo; J A León; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Viral load and CD69 molecule expression on freshly isolated and cultured mitogen-stimulated lymphocytes of children with perinatal HIV-1 infection.

Authors:  M De Martino; M E Rossi; C Azzari; M G Gelli; F Chiarelli; L Galli; A Vierucci
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

4.  Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.

Authors:  A Anselmi; D Vendrame; O Rampon; C Giaquinto; M Zanchetta; A De Rossi
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

5.  HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.

Authors:  Emmanouil Papasavvas; Elizabeth C Moore; Junwei Sun; Livio Azzoni; Maxwell Pistilli; Karam Mounzer; Jane Shull; Jay R Kostman; Luis J Montaner
Journal:  AIDS Res Hum Retroviruses       Date:  2008-09       Impact factor: 2.205

6.  Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Authors:  S Resino; M L Abad; J Navarro; J M Bellón; S Sánchez-Ramón; M Angeles Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

7.  Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.

Authors:  Salvador Resino; Isabel Galán; José M Bellón; M Luisa Navarro; Juan Antonio León; M Angeles Muñoz-Fernandez
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

8.  Preserved immune system in long-term asymptomatic vertically HIV-1 infected children.

Authors:  S Resino; R Correa; J M Bellón; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

9.  Effect of cytomegalovirus co-infection on normalization of selected T-cell subsets in children with perinatally acquired HIV infection treated with combination antiretroviral therapy.

Authors:  Suad Kapetanovic; Lisa Aaron; Grace Montepiedra; Patricia Anthony; Kasalyn Thuvamontolrat; Savita Pahwa; Sandra Burchett; Adriana Weinberg; Andrea Kovacs
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

10.  Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.

Authors:  Shamanthi Jayasooriya; Thushan I de Silva; Jainaba Njie-jobe; Chilel Sanyang; Alison M Leese; Andrew I Bell; Karen A McAulay; Peng Yanchun; Heather M Long; Tao Dong; Hilton C Whittle; Alan B Rickinson; Sarah L Rowland-Jones; Andrew D Hislop; Katie L Flanagan
Journal:  PLoS Pathog       Date:  2015-03-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.